Beijing Luzhu Biotechnology Co., Ltd. (HKG:2480)

HKG:2480 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Selling, General & Admin	45.63	64.8	87.01	85.83	60.22
Research & Development	105.03	135.13	172.69	91.43	42.98
Other Operating Expenses	1.14	0.75	0.6	3.14	9.04
Operating Expenses	151.81	200.67	260.3	180.39	112.24
Operating Income	-151.81	-200.67	-260.3	-180.39	-112.24
Interest Expense	-3.77	-1.44	-0.84	-0.72	-0.6
Interest & Investment Income	2.14	3.52	6.01	0.25	0.04
Currency Exchange Gain (Loss)	-1.1	1	6.73	1	0
Other Non Operating Income (Expenses)	15.05	18.55	-12.38	-559.41	-437.35
EBT Excluding Unusual Items	-139.5	-179.06	-260.78	-739.28	-550.15
Gain (Loss) on Sale of Investments	9.32	11.1	11.38	13.87	10.8
Gain (Loss) on Sale of Assets	-0.25	-0.25	0.06	-0	-0.01
Other Unusual Items	-	-0.03	-	0.24	-
Pretax Income	-135.87	-168.24	-249.35	-725.18	-539.36
Net Income	-135.87	-168.24	-249.35	-725.18	-539.36
Net Income to Common	-135.87	-168.24	-249.35	-725.18	-539.36
Shares Outstanding (Basic)	201	202	199	146	91
Shares Outstanding (Diluted)	201	202	199	146	91
Shares Change (YoY)	-0.85%	1.48%	36.65%	60.39%	-
EPS (Basic)	-0.68	-0.83	-1.25	-4.98	-5.94
EPS (Diluted)	-0.68	-0.83	-1.25	-4.98	-5.94
Free Cash Flow	-220.75	-180.45	-275.72	-285.47	-79.08
Free Cash Flow Per Share	-1.10	-0.89	-1.39	-1.96	-0.87
EBITDA	-125.34	-179.15	-248.65	-174.97	-109.42
D&A For EBITDA	26.46	21.53	11.65	5.42	2.83
EBIT	-151.81	-200.67	-260.3	-180.39	-112.24

Source: S&P Global Market Intelligence. Standard template. Financial Sources.